Product Information
INDOMETHACIN ER 75 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2099 per EA under NDC 68462032560. Its NADAC has been published 470 times since Oct 4, 2017.
FDA first approved this application on Jun 22, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462032560
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
INDOMETHACINApproval Type
Generic (ANDA)
FDA Application
ANDA203501FDA Approved
6/22/2017
TE Code
AB
On Market Since
6/22/2017
Pharmacological Classes
Price Statistics
The NADAC for INDOMETHACIN ER 75 MG CAPSULE has been published 470 times since Oct 4, 2017, and over the history we have for it it has declined 72.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2099 per EA |
|---|---|
| All-time high | $0.8837 (Mar 14, 2018) |
| All-time low | $0.1511 (Nov 20, 2024) |
| 52-week high | $0.2230 |
| 52-week low | $0.1957 |
| Median price | $0.2429 |
| Average price | $0.2996 |
| Largest weekly change | +72.4% (Nov 20, 2019) |
| Weeks tracked | 470 |
| Tracking since | Oct 4, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
indomethacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of INDOMETHACIN ER 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for INDOMETHACIN ER 75 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2099 per EA (NDC 68462032560), effective Sep 30, 2026.
How has the price of INDOMETHACIN ER 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for INDOMETHACIN ER 75 MG CAPSULE has declined 72.8%. It has been tracked across 470 weekly CMS publications since Oct 4, 2017.
What are the highest and lowest recorded NADAC prices for INDOMETHACIN ER 75 MG CAPSULE?
Since Oct 4, 2017, the NADAC for INDOMETHACIN ER 75 MG CAPSULE has ranged from a low of $0.1511 (Nov 20, 2024) to a high of $0.8837 (Mar 14, 2018), with a median of $0.2429 per EA.
Are there cheaper alternatives to INDOMETHACIN ER 75 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as INDOMETHACIN ER 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures INDOMETHACIN ER 75 MG CAPSULE?
INDOMETHACIN ER 75 MG CAPSULE (NDC 68462032560) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.